title: The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.
authors.affiliation: Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen.
authors.forename: L H J
authors.initials: LHJ
authors.lastname: Simkens
authors.affiliation: Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen.
authors.forename: J
authors.initials: J
authors.lastname: Tol
authors.affiliation: Department of Medical Cell Biophysics, Faculty of Sciences and Technology, Twente University, Enschede.
authors.forename: L W M M
authors.initials: LWMM
authors.lastname: Terstappen
authors.affiliation: Department of Epidemiology, Biostatistics, and Health Technology Assessment.
authors.forename: S
authors.initials: S
authors.lastname: Teerenstra
authors.affiliation: Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen.
authors.forename: C J A
authors.initials: CJA
authors.lastname: Punt
authors.affiliation: Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: i.nagtegaal@pathol.umcn.nl.
authors.forename: I D
authors.initials: ID
authors.lastname: Nagtegaal
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D014408:Biomarkers, Tumor / Q000097:blood*; D002277:Carcinoma / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D015179:Colorectal Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D019937:Diagnostic Techniques and Procedures; D018450:Disease Progression; D042783:Endothelial Cells / Q000473:pathology*; D006801:Humans; D020360:Neoadjuvant Therapy; D009360:Neoplastic Cells, Circulating / Q000473:pathology; D011237:Predictive Value of Tests; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D000068258:Bevacizumab